Wednesday, January 4, 2017

BRIEF-FDA accepts for filing supplemental new drug application for Liletta

* FDA accepts for filing supplemental new drug application

(SNDA) for Liletta (levonorgestrel-releasing intrauterine

system) 52 mg

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)